Emc Capital Management Cytokinetics Inc Transaction History

Emc Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $732,406 - $1.13 Million	-24,627 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$19.79 - $26.99 $83,850 - $114,356	-4,237 Reduced 14.68%	24,627 $487,000
Q1 2021 May 05, 2021	BUY	$18.57 - $25.68 $137,863 - $190,648	7,424 Added 34.63%	28,864 $671,000
Q4 2020 Feb 24, 2021	BUY	$15.26 - $28.61 $327,174 - $613,398	21,440 New	21,440 $446,000

405

125M

4.61M

2.46M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.66B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

Stay updated on Emc Capital Management with notifications on news.